Article
Targeting mutant p53 in cancer: a long road to precision therapy
3 Nov 2016
Abstract excerpt
The TP53 tumor suppressor is the most frequently mutated gene in human cancers. In recent years, a blooming of research efforts based on both cell lines and mouse models have highlighted how deeply mutant p53 proteins affect fundamental cellular pathways with cancer-promoting outcomes. Neomorphic mutant p53 activities spread over multiple levels, impinging on chromatin structure, transcriptional regulation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
